Vaxart expands IP portfolio with European patent protection
Vaxart expanded its intellectual property portfolio with a European patent protecting proprietary norovirus vaccine technology.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.